Benzinga | Aug 5, 2020 04:53PM EDT

bluebird bio Q2 EPS $(0.36) Up From $(3.55) YoY, Sales $198.89M Up From $13.30M YoY

bluebird bio (NASDAQ:BLUE) reported quarterly losses of $(0.36) per share. This is a 89.86 percent increase over losses of $(3.55) per share from the same period last year. The company reported $198.89 million in sales this quarter. This is a 1.40K percent increase over sales of $13.30 million the same period last year.